Cargando…

The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines

To estimate the extent that BP measurement variability may drive over- and underdiagnosis of ‘hypertension’ when measurements are made according to current guidelines. METHODS: Using data from the National Health and Nutrition Examination Survey and empirical estimates of within-person variability,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bell, Katy, Doust, Jenny, McGeechan, Kevin, Horvath, Andrea Rita, Barratt, Alexandra, Hayen, Andrew, Semsarian, Christopher, Irwig, Les
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	ORIGINAL PAPERS: Diagnostic aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810411/ https://www.ncbi.nlm.nih.gov/pubmed/32773652 http://dx.doi.org/10.1097/HJH.0000000000002614

Ejemplares similares

Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
por: Kim, Byong-Kyu, et al.
Publicado: (2020)

Hypertension defined by the 2017 ACC/AHA guideline is more accurate than 2018 ESC/ESH for detecting early vascular aging in young adults
por: de Souza, Mariana P., et al.
Publicado: (2022)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)

Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review
por: Kazda, Luise, et al.
Publicado: (2021)

Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review
por: Kazda, Luise, et al.
Publicado: (2019)

Overdiagnosis or not? 2017 ACC/AHA high blood pressure clinical practice guideline: Consequences of intellectual conflict of interest
por: Miyazaki, Kei
Publicado: (2018)

Implementation of the 2018 ESC/ESH Guidelines for the management of hypertension in primary care: the HYPEDIA study
por: Kollias, Anastasios, et al.
Publicado: (2022)

Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
por: Floyd, Christopher N
Publicado: (2020)

Women’s views on overdiagnosis in breast cancer screening: a qualitative study
por: Hersch, Jolyn, et al.
Publicado: (2013)

An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population
por: McGeechan, Kevin, et al.
Publicado: (2014)

Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data
por: Bell, Katy J L, et al.
Publicado: (2014)

Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
por: Pathirana, Thanya, et al.
Publicado: (2019)

Too much or too little medicine? Overdiagnosis, underdiagnosis, overtreatment and undertreatment in respiratory diseases
por: Dobler, Claudia C.
Publicado: (2019)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial
por: Hersch, Jolyn, et al.
Publicado: (2017)

Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial
por: Hersch, Jolyn, et al.
Publicado: (2021)

ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study
por: Mortensen, Martin Bødtker, et al.
Publicado: (2017)

A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort
por: Santos-Ferreira, Cátia, et al.
Publicado: (2020)

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC()
por: Bloomgarden, Zachary, et al.
Publicado: (2020)

Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension
Publicado: (2007)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
por: Kittleson, Michelle M., et al.
Publicado: (2014)

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
por: Vallejo-Vaz, Antonio J., et al.
Publicado: (2022)

The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial
por: Hersch, Jolyn, et al.
Publicado: (2014)

Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA
por: Kakadiaris, Ioannis A., et al.
Publicado: (2018)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA Guidelines
por: Xia, Yiwei, et al.
Publicado: (2021)

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022)

Public Opinions about Overdiagnosis: A National Community Survey
por: Moynihan, Ray, et al.
Publicado: (2015)

Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts
por: de las Heras Gala, Tonia, et al.
Publicado: (2016)

Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study
por: Arshi, Banafsheh, et al.
Publicado: (2021)

Recombinant Activated Protein C (rhAPC) Affects Lipopolysaccharide-Induced Mechanical Compliance Changes and Beat Frequency of mESC-Derived Cardiomyocyte Monolayers
por: Temiz Artmann, Aysegül, et al.
Publicado: (2022)

Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline
por: Kibria, Gulam Muhammed Al, et al.
Publicado: (2018)

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
por: Wenger, Nanette K.
Publicado: (2019)

Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline
por: Hosseini, Mostafa, et al.
Publicado: (2019)

What is new in ACC/AHA 2017 focused update of valvular heart disease guidelines
por: Özkan, Mehmet
Publicado: (2017)

Society for Cardiovascular Magnetic Resonance perspective on the 2021 AHA/ACC Chest Pain Guidelines
por: Arai, Andrew E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aod6gue8rpfg6v0ll78t5n8leo